CINGULATE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6611 USD | -4.59% |
|
-8.54% | -91.36% |
| May. 21 | FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD | CI |
| May. 08 | Cingulate Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
bae2198c4900a167352fe2ed0c4ad.XLHtNua5Lva10HAGqFCDYw2RjvGJgYZWKfvqj40FAwg.KIOHQKyJVsL5vxNp-gHHFUHY7ci66eoifJWD4uBHekcwiIJgrOFhoNaiJQ~41f433913303c02801c6a9d007d7523f
